Danaher Corporation $DHR Stock Sold by Cortland Associates Inc. MO

Cortland Associates Inc. MO decreased its position in Danaher Corporation (NYSE:DHR) by 7.1% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 146,216 shares of the conglomerate’s stock after selling 11,147 shares during the quarter. Danaher comprises 4.7% of Cortland Associates Inc. MO’s holdings, making the stock its 8th largest position. Cortland Associates Inc. MO’s holdings in Danaher were worth $32,394,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of DHR. BlackRock Inc. bought a new stake in shares of Danaher in the 2nd quarter worth approximately $10,492,520,000. Wellington Management Group LLP grew its holdings in shares of Danaher by 10.4% during the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock valued at $3,108,031,000 after purchasing an additional 1,542,310 shares during the last quarter. Jupiter Topco LLC bought a new position in shares of Danaher during the 2nd quarter valued at $1,456,317,000. Generation Investment Management LLP purchased a new position in Danaher in the 2nd quarter worth $1,287,949,000. Finally, Bank of America Corp DE purchased a new position in Danaher in the 2nd quarter worth $993,846,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling

In other news, CAO Christopher Bouda sold 7,598 shares of the firm’s stock in a transaction dated Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total value of $1,782,186.88. Following the completion of the sale, the chief accounting officer directly owned 9,107 shares of the company’s stock, valued at approximately $2,136,137.92. This trade represents a 45.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 10.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on DHR. TD Cowen upped their price target on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research report on Thursday, October 22nd. Barclays raised their price objective on Danaher from $255.00 to $260.00 and gave the company an “overweight” rating in a research note on Thursday, October 22nd. JPMorgan Chase & Co. boosted their target price on Danaher from $250.00 to $270.00 and gave the company an “overweight” rating in a research note on Thursday, October 22nd. Evercore reissued an “outperform” rating and issued a $230.00 target price on shares of Danaher in a research note on Monday, July 6th. Finally, Robert W. Baird increased their target price on Danaher from $246.00 to $254.00 and gave the company an “outperform” rating in a report on Thursday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $242.91.

Danaher Price Performance

DHR opened at $228.04 on Tuesday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63. The stock has a market capitalization of $160.44 billion, a PE ratio of 37.32, a price-to-earnings-growth ratio of 2.94 and a beta of 0.76. The stock’s 50 day moving average price is $219.09 and its 200-day moving average price is $201.73. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, topping analysts’ consensus estimates of $1.92 by $0.19. The company had revenue of $6.55 billion during the quarter, compared to analyst estimates of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The firm’s revenue was up 8.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.89 earnings per share. On average, equities research analysts predict that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th were issued a $0.40 dividend. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio is 26.19%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.